Inoperable recurrent rectal cancer: Results of a prospective trial with radiation therapy and razoxane
- 30 September 1994
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 30 (2) , 419-425
- https://doi.org/10.1016/0360-3016(94)90023-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Mitomycin C, 5-fluorouracil and radiation in advanced, locally recurrent rectal cancerThe British Journal of Radiology, 1992
- Results of two randomised clinical trials of neutron therapy in rectal adenocarcinomaRadiotherapy and Oncology, 1987
- The amsterdam fast neutron therapy project: A final reportInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Residual, recurrent, or unresectable gastrointestinal cancer. Role of radiation in single or combined modality treatmentCancer, 1985
- Combination chemo-radiotherapy for residual, recurrent or inoperable carcinoma of the rectum: E.C.O.G. study (EST 3276)International Journal of Radiation Oncology*Biology*Physics, 1985
- ICRF-159: Current status and clinical prospectsPublished by Elsevier ,1977
- ICRF 159, (±) 1,2-di(3,5-dioxopiperazin-1-yl)propane NSC-129,943; RazoxaneCancer Treatment Reviews, 1976
- Proceedings: Analysis of the antimetastatic action of the antimitotic agent ICRF 159British Journal of Cancer, 1974
- Control of Malignant Metastases by ICRF 159Nature, 1969
- Antitumour Activity in a Series of bisDiketopiperazinesNature, 1969